AI Guardrails Stripped From Meta Google Models Raises Safety Concerns Micron Shares Eye Best Month Since 1987 as Analysts Highlight Value Opportunity Quarles Earns Mergers Acquisitions MidMarket Deals of the Year Recognition for Portfolio Company Sale IBM Gains Over 27 Billion in Market Cap Following Trumps Quantum Computing Support Berkshire Hathaway Builds 26 Billion Delta Air Lines Stake Marking Return to Airlines Fed Dissenters Explain No Votes Disagreement Over Signaling Rate Cut Path GTN Q1 2026 Earnings Negative EPS Surprise Sends Shares Lower DSGN Q1 2026 Earnings NarrowerthanExpected Loss Despite No Revenue HYPD Q1 2026 Earnings Significant EPS Miss Sends Shares Lower TLPH Q1 2026 Earnings Significant EPS Beat as PreRevenue Biotech Advances Pipeline FMAO Q1 2026 Earnings EPS Beats Estimates by 381 Despite Negative Stock Reaction RBA Q1 2026 Earnings EPS Surpasses Expectations Stock Gains Modestly Cheetah Net Supply Chain Service CTNT Slides 556 as Shares Test Key Support Levels Canadian Pacific Kansas City CP Surges 33 Testing Key Resistance at 9358 FlyE Group Inc FLYE Soars 10 Key Levels to Watch After Breakout MasTec MTZ Shows Modest Decline Amid Infrastructure Sector Pullback Cohen Steers Total Return Realty Fund RFI Inches Higher Amid Steady Support Unum Group UNM Holds Steady Near 84 as Market Weighs Insurance Sector Sentiment TAVIR Rights Plunge Over 35 as Tavia Acquisition Corp Faces Steep Decline BingEx Limited FLX Rallies Above Key Support Resistance Test Looms BioAge Labs BIOA Jumps 46 as Biotech Momentum Drives Price Toward Key Resistance SRX Health Solutions SRXH Holds Near Support After Modest Uptick Cardlytics CDLX Edges Higher Analyzing the Recent Uptick and Key Technical Levels Elon Musk and Sam Altmans Rivalry Intensifies on Wall Street TRIN Q1 2026 Earnings EPS Beats Estimates by 116 Shares Decline Slightly Nurix Therapeutics Shares Dip Slightly Holds Above Key Support NRIX LION Q1 2026 Earnings Strong EPS Surprise of 5296 Drives Stock Uptick MDIA Q3 2023 Earnings Negative EPS Amidst Ongoing Industry Challenges ANNX Q1 2026 Earnings Clinical Pipeline Progress Drives EPS Beat as Stock Dips on Broader Biotech Headwinds BGSI Q1 2026 Earnings Modest EPS Miss Amid Stable Operations GRRR Q4 2025 Earnings Significant EPS Miss but Stock Rises Over 12 ORGN Q4 2025 Earnings EPS Well Below Estimates as Company Continues PreRevenue Stage CPSH Q1 2026 Earnings Loss Per Share Misses Estimates Broadly as Stock Rises